N6-methylandenosine-related lncRNAs play an important role in the prognosis and immune microenvironment of pancreatic ductal adenocarcinoma
Abstract Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive, fatal tumor. N6-methylandenosine (m6A) methylation is the major epigenetic modification of RNA including lncRNAs. The roles of m6A-related lncRNAs in PDAC have not been fully clarified. This study aims to assess gene signatures...
Guardado en:
Autores principales: | YuHai Hu, YiPing Chen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/05836a8337c04300898dd9081f967c4c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Identification of N6-methylandenosine related LncRNAs biomarkers associated with the overall survival of osteosarcoma
por: Pei Zhang, et al.
Publicado: (2021) -
LncRNAs: Novel Biomarkers for Pancreatic Cancer
por: Soudeh Ghafouri-Fard, et al.
Publicado: (2021) -
A Pan-Cancer Landscape of HOX-Related lncRNAs and Their Association With Prognosis and Tumor Microenvironment
por: Wei Shao, et al.
Publicado: (2021) -
KRAS-related noncoding RNAs in pancreatic ductal adenocarcinoma
por: Shuang-Ni Yu, et al.
Publicado: (2016) -
Pancreatic ductal adenocarcinoma immune microenvironment and immunotherapy prospects
por: Ke-Yu Li, et al.
Publicado: (2020)